...March 17). The drugs include generics, as well as Ambien and Ambien CR from Sanofi; Edluar...

...buccal soluble film; and insomnia drug Sublinox zolpidem. Meda will grant Valeant a license for Sublinox...
...once the JV in Canada is terminated. Onsolis is an adhesive disc formulation of fentanyl. Sublinox...

...mental function. The drugs include generics, as well as Ambien and Ambien CR from Sanofi; Edluar...

...the review. The drugs include generics, as well as Ambien and Ambien CR from Sanofi; Edluar...

...require alertness. The drugs include generics and well as Ambien and Ambien CR from Sanofi; Edluar...
...women will be lowered to 5 mg from 10 mg for the immediate-release products Ambien, Edluar...

...sublingual, mucoadhesive zolpidem tablet is marketed in the U.S. as Edluar and in Canada as Sublinox...
...and in Canada as Sublinox to treat short-term insomnia. Meda acquired exclusive, worldwide rights to Edluar...
...21, 2008). Orexo AB (SSE:ORX), Uppsala, Sweden Meda AB (SSE:MEDAA), Solna, Sweden Product: Edluar ( Sublinox...

...Health Canada approved an NDS for Sublinox zolpidem for short-term treatment and symptomatic relief of insomnia...
...in the U.S. as Edluar to treat short-term insomnia. Meda acquired exclusive, worldwide rights to Sublinox...
...April 21, 2008). Orexo AB (SSE:ORX), Uppsala, Sweden Meda AB (SSE:MEDAA), Solna, Sweden Product: Sublinox edluar...

...Meda launched 5 and 10 mg sublingual Edluar zolpidem (formerly Sublinox ) in the U.S. for...

...FDA approved an NDA from Orexo for sublingual Edluar zolpidem (formerly Sublinox) to treat insomnia. The...
...U.S. next half. Orexo AB (SSE:ORX), Uppsala, Sweden Product: Edluar ( OX 22 ; formerly Sublinox...

...the partners will form JVs in Australia, Canada and Mexico to develop and commercialize Meda’s Sublinox...
...profit sharing. Meda has exclusive, worldwide rights from Orexo AB (SSE:ORX, Uppsala, Sweden) to market Sublinox...